tiprankstipranks
Advertisement
Advertisement

RENXF Stock Latest News

Renalytix’s KidneyIntelX Study Update: What Ongoing Real-World Data Means for RENXF Investors
Company AnnouncementsRenalytix’s KidneyIntelX Study Update: What Ongoing Real-World Data Means for RENXF Investors
3d ago
RENXF
Renalytix’s KidneyIntelX Test Shows Two-Year Real-World Benefit in Diabetic Kidney Disease
PremiumCompany Announcements
Renalytix’s KidneyIntelX Test Shows Two-Year Real-World Benefit in Diabetic Kidney Disease
2M ago
Renalytix boosts kidneyintelX.dkd capacity and advances CE marking for European push
PremiumCompany Announcements
Renalytix boosts kidneyintelX.dkd capacity and advances CE marking for European push
4M ago
Renalytix Grows Revenue and Integration Footprint as It Pursues National Rollout of KidneyintelX.dkd
PremiumCompany Announcements
Renalytix Grows Revenue and Integration Footprint as It Pursues National Rollout of KidneyintelX.dkd
5M ago
Renalytix Lifts Revenue as KidneyintelX Expansion and Distribution Talks Gather Pace
PremiumCompany Announcements
Renalytix Lifts Revenue as KidneyintelX Expansion and Distribution Talks Gather Pace
5M ago
Renalytix CEO Boosts Stake as Kidney Disease Test Rollout Advances
PremiumCompany AnnouncementsRenalytix CEO Boosts Stake as Kidney Disease Test Rollout Advances
6M ago
Renalytix CFO Increases Stake as KidneyintelX.dkd Deployment Expands
Premium
Company Announcements
Renalytix CFO Increases Stake as KidneyintelX.dkd Deployment Expands
6M ago
Renalytix CFO Increases Stake as Kidney Disease Test Gains Traction
Premium
Company Announcements
Renalytix CFO Increases Stake as Kidney Disease Test Gains Traction
6M ago
Renalytix CEO Increases Stake Amid Expansion of Kidney Disease Test
PremiumCompany Announcements
Renalytix CEO Increases Stake Amid Expansion of Kidney Disease Test
6M ago
Renalytix Eyes Revenue Growth as Kidney Diagnostic Expands U.S. Footprint
PremiumCompany Announcements
Renalytix Eyes Revenue Growth as Kidney Diagnostic Expands U.S. Footprint
6M ago
Renalytix Adds Three U.S. Kidney Care Integrations and Deepens Tempus AI Collaboration
PremiumCompany Announcements
Renalytix Adds Three U.S. Kidney Care Integrations and Deepens Tempus AI Collaboration
7M ago
Renalytix Secures Shareholder Support at AGM and Advances Kidney Disease Diagnostics
PremiumCompany Announcements
Renalytix Secures Shareholder Support at AGM and Advances Kidney Disease Diagnostics
8M ago
Renalytix Expands Kidney Disease Test Adoption and Strategic Partnerships
PremiumCompany AnnouncementsRenalytix Expands Kidney Disease Test Adoption and Strategic Partnerships
8M ago
Renalytix AI Reports Strong Growth and Strategic Expansion
Premium
Company Announcements
Renalytix AI Reports Strong Growth and Strategic Expansion
9M ago
Renalytix’s KidneyIntelX.dkd Test Gains Recognition for Advancing CKD Management
Premium
Company Announcements
Renalytix’s KidneyIntelX.dkd Test Gains Recognition for Advancing CKD Management
9M ago
Renalytix Publishes 2025 Annual Report and Expands Kidney Disease Test Deployment
PremiumCompany Announcements
Renalytix Publishes 2025 Annual Report and Expands Kidney Disease Test Deployment
9M ago
Renalytix Reports Strong Fiscal 2025 Results and Strategic Expansion
PremiumCompany Announcements
Renalytix Reports Strong Fiscal 2025 Results and Strategic Expansion
10M ago
Renalytix Secures £860k in R&D Tax Credits
PremiumCompany Announcements
Renalytix Secures £860k in R&D Tax Credits
10M ago
Renalytix Enhances Financial Position with $4M Bond Conversion
PremiumCompany Announcements
Renalytix Enhances Financial Position with $4M Bond Conversion
10M ago
Renalytix Seeks CE Mark for KidneyIntelX.dkd Amid Growing Global Interest
PremiumCompany AnnouncementsRenalytix Seeks CE Mark for KidneyIntelX.dkd Amid Growing Global Interest
11M ago
Renalytix Secures £7.05 Million in Oversubscribed Fundraise
Premium
Company Announcements
Renalytix Secures £7.05 Million in Oversubscribed Fundraise
11M ago
Renalytix Updates Revenue Guidance Amid New Tempus Collaboration
Premium
Company Announcements
Renalytix Updates Revenue Guidance Amid New Tempus Collaboration
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >